Optical Coherence Tomography to Evaluate Ticagrelor and Clopidogrel

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2014
A number of 352 patients scheduled for elective percutaneous coronary intervention (PCI) with a native coronary stenosis suitable for DES implantation and OCT imaging are openly randomized 1:1 to either BRILINTA™ (ticagrelor) or Plavix® (clopidogrel bisulfate).
Epistemonikos ID: cf2e4e417fce43edc63ecb8d55c74ea23ae41d6c
First added on: May 11, 2024